|
Market Cap (6-Jul) $277,062,656 (480th) |
Close (30-Jun) $3.40 |
Volume (30-Jun) 0 |
Shortsold (6-Aug) 667 (0.00%) (670th) |
|
52w High $3.12 |
52w Low $2.13 |
P/E 22.37 |
EPS 0.1 |
AFP released this announcement to the ASX on 14 July 2021, 15:59. The announcement is not marked as price sensitive, and is 1 page(s) in length and 262.89kb in size.
You can view all announcements from AFP and see how they appear on a price chart on the announcements page.
At the date of this announcement, AFP was 0.000% short sold according to ASIC data. It was ranked the 692nd most shorted stock on the ASX. It is now ranked as the 670th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (06 August 2021).
| Other Recent Announcements from AFP | |
|---|---|
| Notice of Annual Meeting of Shareholders 2023 | 30 June 2023, 7:30 |
| Dividend/Distribution - AFP | 30 May 2023, 14:13 |
| Annual Meeting and Closing Date for Director Nominations | 26 May 2023, 14:58 |
| D&O Ongoing Disclosure - Louise Clayton | 14 July 2021, 15:59 |
| Capital Change Notice - Issue of ordinary shares | 14 July 2021, 15:51 |
| Maxigesic Oral Liquid gets first regulatory approval | 14 July 2021, 9:20 |
| Maxigesic IV launches in Germany and Austria | 8 July 2021, 7:30 |
You must be logged in to post a reply.
AFT Pharmaceuticals 